Genomic and Phenotypic Characterization of Streptomyces marxii sp. nov., Producer of Kinanthraquinone B
Microorganisms · 27.05.2026 · 14 (6) · 1206
DOI: 10.3390/microorganisms14061206 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microorganisms, online erschienen am 27.05.2026. Verfasst von Mikhail Yu Dobryakov und 2 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Translational Medicine, Sirius University of Science and Technology, Sochi 354340, Russia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
Describing novel microbial species opens access to uncharted biosynthetic gene clusters and their associated secondary metabolites, offering fresh opportunities in the search for new antibiotics urgently needed to combat multidrug resistance. In this study, we describe a new species of Streptomyces, S. marxii sp. nov. (type strain VKM Ac-3100), an actinobacterium isolated from soil in the Yaroslavl Region of Russia. Using a polyphasic taxonomic approach that included whole-genome sequencing (WGS), we found that the strain’s average nucleotide identity (ANI) and digital DNA–DNA hybridisation (dDDH) values relative to its closest relative, S. maoxianensis, were 92.53% and 47.9%, respectively. Both values fell significantly below the species delimitation thresholds. Functional screening using the pDualrep2 dual fluorescent reporter system identified a unique SOS-silent antimicrobial profile characterised by growth inhibition without induction of the SOS response or translation stress. High-resolution mass spectrometry (HRMS) and genomic mining revealed that this activity is linked to the production of kinanthraquinone B ([M+H]+ m/z 275.0550), a rare polycyclic aromatic polyketide. Genomic analysis identified a specialised type II polyketide synthase (T2PKS) biosynthetic gene cluster (BGC) with evidence of acquisition via horizontal gene transfer (HGT). Our findings characterise S. marxii as a promising natural producer of rare catalytic inhibitors of DNA topoisomerases II and IV, offering a scaffold for the development of antibiotics with potentially lower genotoxicity.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Center for Translational Medicine, Sirius University of Science and Technology, Sochi 354340, Russia.
- Department of Biology, Lomonosov Moscow State University, Moscow 119991, Russia.
Förderung
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Dobryakov, M. Y., Buyuklyan, J. A., & Biryukov, M. V. (2026). Genomic and Phenotypic Characterization of Streptomyces marxii sp. nov., Producer of Kinanthraquinone B. Microorganisms, 14(6), 1206. https://doi.org/10.3390/microorganisms14061206
Vancouver
Dobryakov MY, Buyuklyan JA, Biryukov MV. Genomic and Phenotypic Characterization of Streptomyces marxii sp. nov., Producer of Kinanthraquinone B. Microorganisms. 2026;14(6):1206. doi:10.3390/microorganisms14061206
BibTeX
@article{Dobryakov2026,
author = {Dobryakov, Mikhail Yu and Buyuklyan, Julia A and Biryukov, Mikhail V},
title = {Genomic and Phenotypic Characterization of Streptomyces marxii sp. nov., Producer of Kinanthraquinone B},
journal = {Microorganisms},
year = {2026},
volume = {14},
number = {6},
pages = {1206},
doi = {10.3390/microorganisms14061206}
}
EUVIMED